SEARCH

SEARCH BY CITATION

References

  • Arima S., Endo Y., Yaoita H., Omata K., Ogawa S., Tsunoda K., Abe M., Takeuchi K., Abe K. and Ito S. (1997) Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J. Clin. Invest. 100, 28162823.
  • Barnes J. M., Steward L. J., Barber P. C. and Barnes N. M. (1993) Identification and characterisation of angiotensin II receptor subtypes in human brain. Eur. J. Pharmacol. 230, 251258.
  • Chen Z. L. and Strickland S. (1997) Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91, 917925.
  • Cote F., Do T. H., Laflamme L., Gallo J. M. and Gallo-Payet N. (1999) Activation of the AT(2) receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum. J. Biol. Chem. 274, 31 68631 692.
  • Dahlof B., Devereux R. B., Kjeldsen S. E. et al. (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359, 9951003.
  • Dai W. J., Funk A., Herdegen T., Unger T. and Culman J. (1999) Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke 30, 23912398; 2398–2399.
  • Darimont C., Vassaux G., Gaillard D., Ailhaud G. and Negrel R. (1994) In situ microdialysis of prostaglandins in adipose tissue: stimulation of prostacyclin release by angiotensin II. Int. J. Obes. Relat. Metab. Disord. 18, 783788.
  • Dehmer T., Heneka M. T., Sastre M., Dichgans J. and Schulz J. B. (2004) Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation. J. Neurochem. 88, 494501.
  • Deplanque D., Gele P., Petrault O. et al. (2003) Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J. Neurosci. 23, 62646271.
  • Desvergne B. and Wahli W. (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev. 20, 649688.
  • Fey M. F., Moffat G. J., Vik D. P., Meisenhelder J., Saris C. J., Hunter T. and Tack B. F. (1996) Complete structure of the murine p36 (annexin II) gene. Identification of mRNAs for both the murine and the human gene with alternatively spliced 5′ noncoding exons. Biochim. Biophys. Acta 1306, 160170.
  • Fu M., Zhang J., Zhu X., Myles D. E., Willson T. M., Liu X. and Chen Y. E. (2001) Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3. J. Biol. Chem. 276, 45 88845 894.
  • De Gasparo M., Catt K. J., Inagami T., Wright J. W. and Unger T. (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 52, 415472.
  • Gendron L., Cote F., Payet M. D. and Gallo-Payet N. (2002) Nitric oxide and cyclic GMP are involved in angiotensin II AT(2) receptor effects on neurite outgrowth in NG108-15 cells. Neuroendocrinology 75, 7081.
  • Gendron L., Payet M. D. and Gallo-Payet N. (2003) The angiotensin type 2 receptor of angiotensin II and neuronal differentiation: from observations to mechanisms. J. Mol. Endocrinol. 31, 359372.
  • Gohlke P., Pees C. and Unger T. (1998) AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 31, 349355.
  • Heneka M. T., Landreth G. E. and Feinstein D. L. (2001) Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease. Ann. Neurol. 49, 276.
  • Jacovina A. T., Zhong F., Khazanova E., Lev E., Deora A. B. and Hajjar K. A. (2001) Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation. J. Biol. Chem. 276, 49 35049 358.
  • Jung K. M., Park K. S., Oh J. H. et al. (2003) Activation of p38 mitogen-activated protein kinase and activator protein-1 during the promotion of neurite extension of PC-12 cells by 15-deoxy-delta12,14-prostaglandin J2. Mol. Pharmacol. 63, 607616.
  • Kintscher U., Wakino S., Bruemmer D., Goetze S., Graf K., Hsueh W. and Law R. (2002a) TGF-beta(1) induces peroxisome proliferator-activated receptor gamma1 and gamma2 expression in human THP-1 monocytes. Biochem. Biophys. Res. Commun. 297, 794.
  • Kintscher U., Lyon C., Wakino S. et al. (2002b) PPARalpha inhibits TGF-beta-induced beta5 integrin transcription in vascular smooth muscle cells by interacting with Smad4. Circ. Res. 91, e3544.
  • Kintscher U., Lyon C. J. and Law R. E. (2004) Angiotensin II, PPAR-gamma and atherosclerosis. Front. Biosci. 9, 359369.
  • Laflamme L., Gasparo M., Gallo J. M., Payet M. D. and Gallo-Payet N. (1996) Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors. J. Biol. Chem. 271, 22 72922 735.
  • Li J., Culman J., Hortnagl H. et al. (2005) Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J. 19, 617619.
  • Lucius R., Gallinat S., Rosenstiel P., Herdegen T., Sievers J. and Unger T. (1998) The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J. Exp. Med. 188, 661670.
  • MacGregor D. P., Murone C., Song K., Allen A. M., Paxinos G. and Mendelsohn F. A. (1995) Angiotensin II receptor subtypes in the human central nervous system. Brain Res. 675, 231240.
  • Meffert S., Stoll M., Steckelings U. M., Bottari S. P. and Unger T. (1996) The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol. Cell. Endocrinol. 122, 5967.
  • Peng H., Myers J., Fang X., Stachowiak E. K., Maher P. A., Martins G. G., Popescu G., Berezney R. and Stachowiak M. K. (2002) Integrative nuclear FGFR1 signaling (INFS) pathway mediates activation of the tyrosine hydroxylase gene by angiotensin II, depolarization and protein kinase C. J. Neurochem. 81, 506524.
  • Reinecke K., Lucius R., Reinecke A., Rickert U., Herdegen T. and Unger T. (2003) Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kappaB. FASEB J. 17, 20942096.
  • Rosenfeld M. G. and Glass C. K. (2001) Coregulator codes of transcriptional regulation by nuclear receptors. J. Biol. Chem. 276, 36 86536 868.
  • Sassa Y., Hata Y., Aiello L. P., Taniguchi Y., Kohno K. and Ishibashi T. (2004) Bifunctional properties of peroxisome proliferator-activated receptor gamma1 in KDR gene regulation mediated via interaction with both Sp1 and Sp3. Diabetes 53, 12221229.
  • Satoh T., Furuta K., Suzuki M. and Watanabe Y. (1999) Prostaglandin J2 and its metabolites promote neurite outgrowth induced by nerve growth factor in PC12 cells. Biochem. Biophys. Res. Commun. 258, 5053.
  • Shimazu T., Inoue I., Araki N., Asano Y., Sawada M., Furuya D., Nagoya H. and Greenberg J. H. (2005) A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia. Stroke 36, 353359.
  • Stoll M., Steckelings U. M., Paul M., Bottari S. P., Metzger R. and Unger T. (1995) The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest. 95, 651657.
  • Stroth U., Meffert S., Gallinat S. and Unger T. (1998) Angiotensin II and NGF differentially influence microtubule proteins in PC12W cells: role of the AT2 receptor. Brain Res. Mol. Brain Res. 53, 187195.
  • Tham D. M., Martin-McNulty B., Wang Y. X., Wilson D. W., Vergona R., Sullivan M. E., Dole W. and Rutledge J. C. (2002) Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. Physiol. Genomics 11, 2130.
  • Tischler A. S. and Greene L. A. (1975) Nerve growth factor-induced process formation by cultured rat pheochromocytoma cells. Nature 258, 341342.
  • Tontonoz P., Hu E. and Spiegelman B. M. (1994) Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79, 11471156.
  • Tontonoz P., Hu E. and Spiegelman B. M. (1995) Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr. Opin. Genet. Dev. 5, 571576.
  • Tontonoz P., Nagy L., Alvarez J. G., Thomazy V. A. and Evans R. M. (1998) PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241252.
  • Wright H. M., Clish C. B., Mikami T., Hauser S., Yanagi K., Hiramatsu R., Serhan C. N. and Spiegelman B. M. (2000) A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation. J. Biol. Chem. 275, 18731877.
  • Wu L., Iwai M., Nakagami H., Li Z., Chen R., Suzuki J., Akishita M., De Gasparo M. and Horiuchi M. (2001) Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 104, 27162721.
  • Zhao Y., Biermann T., Luther C., Unger T., Culman J. and Gohlke P. (2003) Contribution of bradykinin and nitric oxide to AT2 receptor-mediated differentiation in PC12 W cells. J. Neurochem. 85, 759767.